Lido Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530K | Sell |
24,422
-190
| -0.8% | -$4.12K | ﹤0.01% | 978 |
|
|
2025
Q1 | $597K | Sell |
24,612
-46
| -0.2% | -$1.12K | ﹤0.01% | 896 |
|
|
2024
Q4 | $515K | Buy |
24,658
+2,650
| +12% | +$55.3K | ﹤0.01% | 919 |
|
|
2024
Q3 | $438K | Buy |
22,008
+7,289
| +50% | +$145K | ﹤0.01% | 904 |
|
|
2024
Q2 | $228K | Buy |
14,719
+75
| +0.5% | +$1.16K | ﹤0.01% | 1113 |
|
|
2024
Q1 | $233K | Sell |
14,644
-842
| -5% | -$13.4K | ﹤0.01% | 1092 |
|
|
2023
Q4 | $260K | Buy |
15,486
+4,275
| +38% | +$71.9K | ﹤0.01% | 990 |
|
|
2023
Q3 | $131K | Sell |
11,211
-23,417
| -68% | -$274K | ﹤0.01% | 989 |
|
|
2023
Q2 | $465K | Sell |
34,628
-11,368
| -25% | -$153K | ﹤0.01% | 691 |
|
|
2023
Q1 | $763K | Buy |
45,996
+33,597
| +271% | +$557K | 0.01% | 494 |
|
|
2022
Q4 | $231K | Sell |
12,399
-5,597
| -31% | -$104K | ﹤0.01% | 773 |
|
|
2022
Q3 | $230K | Sell |
17,996
-657
| -4% | -$8.4K | ﹤0.01% | 747 |
|
|
2022
Q2 | $130K | Sell |
18,653
-16,178
| -46% | -$113K | ﹤0.01% | 786 |
|
|
2022
Q1 | $288K | Buy |
34,831
+3,655
| +12% | +$30.2K | ﹤0.01% | 733 |
|
|
2021
Q4 | $211K | Sell |
31,176
-39,460
| -56% | -$267K | ﹤0.01% | 829 |
|
|
2021
Q3 | $374K | Buy |
70,636
+33,283
| +89% | +$176K | 0.01% | 592 |
|
|
2021
Q2 | $215K | Sell |
37,353
-17,931
| -32% | -$103K | ﹤0.01% | 736 |
|
|
2021
Q1 | $255K | Buy |
+55,284
| New | +$255K | ﹤0.01% | 635 |
|
|
2020
Q4 | – | Sell |
-19,692
| Closed | -$58K | – | 716 |
|
|
2020
Q3 | $58K | Sell |
19,692
-6,512
| -25% | -$19.2K | ﹤0.01% | 548 |
|
|
2020
Q2 | $121K | Sell |
26,204
-720
| -3% | -$3.33K | ﹤0.01% | 494 |
|
|
2020
Q1 | $104K | Sell |
26,924
-1,292
| -5% | -$4.99K | ﹤0.01% | 493 |
|
|
2019
Q4 | $106K | Sell |
28,216
-1,176
| -4% | -$4.42K | ﹤0.01% | 576 |
|
|
2019
Q3 | $156K | Sell |
29,392
-56,912
| -66% | -$302K | 0.01% | 499 |
|
|
2019
Q2 | $331K | Sell |
86,304
-40,099
| -32% | -$154K | 0.02% | 364 |
|
|
2019
Q1 | $644K | Buy |
126,403
+13,380
| +12% | +$68.2K | 0.04% | 222 |
|
|
2018
Q4 | $217K | Buy |
113,023
+12,818
| +13% | +$24.6K | 0.02% | 357 |
|
|
2018
Q3 | $378K | Buy |
100,205
+12,699
| +15% | +$47.9K | 0.04% | 275 |
|
|
2018
Q2 | $273K | Buy |
87,506
+27,766
| +46% | +$86.6K | 0.03% | 310 |
|
|
2018
Q1 | $142K | Buy |
+59,740
| New | +$142K | 0.02% | 368 |
|